PETA joins preclinical CROs at SOT to promote animal testing alternatives
Testing the toxicity of drug candidates in animals is archaic and unreliable according to PETA, which joined preclinical CROs at SOT to put forward alternatives.
Archives for March 27, 2015
US FDA rejects Amgen bid to force biosims firms to share info before review
Biosimilar firms seeking US approval will not have to commit to share manufacturing data with reference drug firms before reviews, after the FDA rejected Amgen’s request for such a rule.
Aarti says US FDA has not detailed GMP problems that earned it an import ban
Aarti Drugs says the US FDA has not provided details of observations that earned its E-22 facility in Tarapur, India an import ban.